Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference60 articles.
1. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis.;Artlett;Arthritis Res. Ther.,2017
2. Liver fibrosis.;Bataller;J. Clin. Invest.,2005
3. Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis.;Billingham;Transplant Proc.,1995
4. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.;Bjoraker;Am. J. Respir. Crit. Care Med.,1998
5. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.;Burgess;Am. J. Physiol. Lung Cell. Mol. Physiol.,2005
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Qingfei xieding prescription ameliorates mitochondrial DNA-initiated inflammation in bleomycin-induced pulmonary fibrosis through activating autophagy;Journal of Ethnopharmacology;2024-05
2. QFAE-nB alleviates pulmonary fibrosis by inhibiting the STING pathway in mice;Journal of Ethnopharmacology;2024-01
3. Pulmonary administration of tetrandrine loaded Zinc-Alginate nanogels attenuates pulmonary fibrosis in rats;International Journal of Pharmaceutics;2024-01
4. Therapeutic potential of traditional Chinese medicine for interstitial lung disease;Journal of Ethnopharmacology;2024-01
5. Targeting TGF-β/periostin signaling by sesamol ameliorates pulmonary fibrosis and improves lung function and survival;The Journal of Nutritional Biochemistry;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3